Skip to content
GGG10 11310 11310 113

Drawing based on the label description. No photo yet.

“10 mg: White to off white, oval shaped, flat faced, beveled edge tablets, double scored on one side and debossed with "G 10 " above "113" on other side”

G10 113 pill

Pill with imprint G10 113 is white, oval, 10 mm and has been identified as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate 2.5 mg / 2.5 mg / 2.5 mg / 2.5 mg. It is used for ADHD. It is supplied by Granules Pharmaceuticals Inc.

Controlled substance: Schedule II

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate 2.5 mg / 2.5 mg / 2.5 mg / 2.5 mg

Imprint
G10 113
Strength
Dextroamphetamine Saccharate 2.5 mg / Amphetamine Aspartate Monohydrate 2.5 mg / Dextroamphetamine Sulfate 2.5 mg / Amphetamine Sulfate 2.5 mg
Used for
ADHD
Color
White
Shape
Oval
Size
10 mm
Score
Breaks into 4 pieces
Form
Tablet
Manufacturer
Granules Pharmaceuticals Inc
Drug class
Stimulant (ADHD medicine)
NDC
70010-113, 70010-113-01, 70010-113-03

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Dextroamphetamine and Amphetamine and and Amphetamine pills and guides

What is Dextroamphetamine and Amphetamine and and Amphetamine used for?

Dextroamphetamine and Amphetamine and and Amphetamine is used for ADHD.

Medicine type
Stimulant (ADHD medicine)
Official uses from the US prescribing label

Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.

Attention Deficit Hyperactivity Disorder (ADHD)

A diagnosis of Attention Deficit Hyperactivity Disorder (ADHD; DSM-IV ®) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. The symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. The symptoms must not be better accounted for by another mental disorder. For the Inattentive Type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental effort; loses things; easily distracted; forgetful. For the Hyperactive-Impulsive Type, at least six of the following symptoms must have persisted for at least 6 months: fidgeting/squirming; leaving seat; inappropriate running/climbing; difficulty with quiet activities; “on the go;” excessive talking; blurting answers; can't wait turn; intrusive. The Combined Type requires both inattentive and hyperactive-impulsive criteria to be met.

Special Diagnostic Considerations

Specific etiology of this syndrome is unknown, and there is no single diagnostic test. Adequate diagnosis requires the use not only of medical but of special psychological, educational, and social resources. Learning may or may not be impaired. The diagnosis must be based upon a complete history and evaluation of the child and not solely on the presence of the required number of DSM-IV ® characteristics.

Need for Comprehensive Treatment Program

Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets are indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, social) for patients with this syndrome. Drug treatment may not be indicated for all children with this syndrome. Stimulants are not intended for use in the child who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. Appropriate educational placement is essential and psychosocial intervention is often helpful. When remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician's assessment of the chronicity and severity of the child's symptoms.

Long-Term Use

The effectiveness of Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets for long-term use has not been systematically evaluated in controlled trials. Therefore, the physician who elects to use Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.

From the FDA-approved label on DailyMed (published Nov 24, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows G 10 113 and the other side has only a score line.
  • It is white, oval, 10 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate

Inactive: Magnesium Stearate, Microcrystalline Cellulose, Silicon Dioxide, Starch, Corn

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Dextroamphetamine and Amphetamine and and Amphetamine pills